Cephalon, Inc.

Overview

Cephalon, Inc. is a biopharmaceutical company specializing in developing and commercializing innovative therapies for areas such as central nervous system disorders, pain management, and oncology. It is a subsidiary of Teva Pharmaceutical Industries, a leading global pharmaceutical company.

Therapeutic areas

API / Drug Master Files

Cephalon, Inc. holds 2 active (2 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• ARMODAFINIL DRUG SUBSTANCEActive2006-08-15
• MODAFINIL DRUG SUBSTANCEActive1996-05-15

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Cephalon, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.